184
Participants
Start Date
January 29, 2018
Primary Completion Date
March 9, 2023
Study Completion Date
June 20, 2023
Roxadustat
Oral tablets
Placebo
Oral tablets
Investigational Site, Brussels
Investigational Site, Darlinghurst
Investigational Site, Liverpool
Investigational Site, Wilrijk
Investigational Site, Victoria Park
Investigational Site, Hasselt
Investigational Site, South Brisbane
Investigational Site, Odense
Investigational Site, Terni
Investigational Site, Yvoir
Investigational Site, Ankara
Investigational Site, Hobart
Investigational Site, Bruges
Investigational Site, Alessandria
Investigational Site, Genova
Investigational Site, Philadelphia
Investigational Site, Milan
Investigational Site, Monza
Investigational Site, Varese
Investigational Site, Incheon
Investigational Site, Incheon
Investigational Site, Nahariya
Investigational Site, Charlottesville
Investigational Site, Madrid
Investigational Site, Madrid
Investigational Site, Madrid
Investigational Site, Charlotte
Investigational Site, Charleston
Investgational site, Atlanta
Investigational Site, Augusta
Investigational Site, Pamplona
Investigational Site, Pembroke Pines
Investigational Site, Yenişehir
Investiational Site, Weston
Investigational Site, Izmir
Investigational Site, Salamanca
Investigational Site, Tours
Investigational Site, Kayseri
Investigational Site, Grenoble
Investigational Site, Bologna
Investigational Site, Düsseldorf
Investigational Site, Düsseldorf
Investigational Site, Seville
Investigational Site, Seville
Investigational Site, Cleveland
Investigational Site, Mayfield Heights
Investigational Site, Cleveland
Investigational Site, Canton
Investigational Site, Valencia
Investigational Site, Meldola
Investigational Site, Münster
Investigational Site, Tel Aviv
Investigational Site, Florence
Investigational Site, Hwasun
Investigational Site, Izmir
Investigational Site, Tekirdağ
Investigational Site, St Louis
Investigational Site, Ẕerifin
Investigational Site, Lecce
Investigational Site, Houston
Investigational Site, Freiburg im Breisgau
Investigational Site, Grand Junction
Investigational Site, München
Investigational Site, Reggio Calabria
Investigational Site, Los Angeles
Investigational Site, Beverly Hills
Investigational Site, Burbank
Investigational Site, Torrance
Investigational Site, Whittier
Investigational Site, Pasadena
Investigational Site, Los Angeles
Investigational Site, Valencia
Investigational Site, Westlake Village
Investigational Site, Encino
Investigational Site, Oceanside
Investigational Site, Laguna Hills
Investigational Site, Ventura
Investigational Site, Bakersfield
Investigational Site, Santa Maria
Investigational Site, Moscow
Investigational Site, Moscow
Investigational Site, Moscow
Investigational Site, Saint Petersburg
Investigational Site, Saint Petersburg
Investigational Site, Saint Petersburg
Investigational Site, Saint Petersburg
Investigational Site, Kaluga
Investigational Site, Omsk
Investigational Site, Kolkata
Investigational Site, Haifa
Investigational Site, Kfar Saba
Investigational Site, Ramat Gan
Investigational Site, Brussels
Investigational Site, Paris
Investigational site, Tel Litwinsky
Investigational Site, Rimini
Investigational Site, Torino
Investigational Site, Vancouver
Investigational Site, London
Investigational Site, Nice
Investigational Site, Dresden
Investigational Site, Leipzig
Investigational Site, Vellore
Investigational Site, Roma
Investigational Site, Bialystok
Investigational Site, Bydgoszcz
Investigational Site, Krakow
Investigational Site, Piła
Investigational Site, Skorzewo
Investigational Site, Słupsk
Investigational Site, Warsaw
Investigational Site, Seoul
Investigational Site, Seoul
Investigational Site, Sabadell
Investigational Site, Barcelona
Investigational Site, Barcelona
Investigational Site, Barcelona
Investigational Site, Barcelona
Investigational Site, Dikimevi
Investigational Site, Boston
Investigational Site, Headington
Investigational Site, Harrow
Investigational Site, London
Investigational Site, Manchester
Lead Sponsor
Collaborators (2)
AstraZeneca
INDUSTRY
Astellas Pharma Inc
INDUSTRY
FibroGen
INDUSTRY